CLINICAL TRIALS PROFILE FOR UPNEEQ
✉ Email this page to a colleague
All Clinical Trials for UPNEEQ
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04831047 ↗ | The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance | Recruiting | University of Miami | Phase 4 | 2021-06-08 | The purpose of the research is to see if Upneeq ( oxymetazoline 0.1% ophthalmic solution) has an effect on eyelid position, eye redness, or patient-perceived appearance of the eyes. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for UPNEEQ
Condition Name
Clinical Trial Locations for UPNEEQ
Trials by Country
Clinical Trial Progress for UPNEEQ
Clinical Trial Phase
Clinical Trial Sponsors for UPNEEQ
Sponsor Name